{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:35:14Z","timestamp":1791668114040,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005242","name":"Universit\u00e9 de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT148593"],"award-info":[{"award-number":["PJT148593"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","award":["2368"],"award-info":[{"award-number":["2368"]}],"id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jcf.2018.03.010","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T09:16:01Z","timestamp":1523610961000},"page":"705-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["CFTR rescue with VX-809 and VX-770 favors the repair of primary airway epithelial cell cultures from patients with class II mutations in the presence of Pseudomonas aeruginosa exoproducts"],"prefix":"10.1016","volume":"17","author":[{"given":"Damien","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bilodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sognigb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9milie","family":"Maill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Ruffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Brochiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2018.03.010_bb0005","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1183\/09031936.00221711","article-title":"Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue","volume":"40","author":"Trinh","year":"2012","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jcf.2018.03.010_bb0010","first-page":"521","article-title":"Ultrastructural morphology of the lung in cystic fibrosis","volume":"21","author":"Dovey","year":"1989","journal-title":"J Submicrosc Cytol Pathol"},{"issue":"6","key":"10.1016\/j.jcf.2018.03.010_bb0015","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0046-8177(96)90011-8","article-title":"Ultrastructure of airway epithelial cell membranes among patients with cystic fibrosis","volume":"21","author":"Carson","year":"1990","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.jcf.2018.03.010_bb0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0046-8177(76)80023-8","article-title":"The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups","volume":"7","author":"Bedrossian","year":"1976","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.jcf.2018.03.010_bb0025","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jcp.24931","article-title":"Dynamically regulated CFTR expression and its functional role in cutaneous wound healing","volume":"230","author":"Dong","year":"2015","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1016\/j.jcf.2018.03.010_bb0030","doi-asserted-by":"crossref","first-page":"C912","DOI":"10.1152\/ajpcell.00215.2010","article-title":"Cystic fibrosis transmembrane conductance regulator is involved in airway epithelial wound repair","volume":"299","author":"Schiller","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"10.1016\/j.jcf.2018.03.010_bb0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1152\/japplphysiol.00915.2010","article-title":"Airway epithelial wounds in rhesus monkey generate ionic currents that guide cell migration to promote healing","volume":"111","author":"Sun","year":"2011","journal-title":"J Appl Physiol"},{"issue":"Pt 8","key":"10.1016\/j.jcf.2018.03.010_bb0040","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1113\/jphysiol.2009.182246","article-title":"Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers","volume":"588","author":"LeSimple","year":"2010","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.jcf.2018.03.010_bb0045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/path.2118","article-title":"Human airway surface epithelial regeneration is delayed and abnormal in cystic fibrosis","volume":"211","author":"Hajj","year":"2007","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.jcf.2018.03.010_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/labinvest.3780024","article-title":"Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2","volume":"80","author":"de Bentzmann","year":"2000","journal-title":"Lab Invest"},{"issue":"9","key":"10.1016\/j.jcf.2018.03.010_bb0055","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1096\/fj.201500166R","article-title":"Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair","volume":"30","author":"Ruffin","year":"2016","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.jcf.2018.03.010_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/thoraxjnl-2017-210298","article-title":"Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator\u2013IL-6\u2013antimicrobial\u2013repair pathway","volume":"73","author":"Saint-Criq","year":"2018","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.jcf.2018.03.010_bb0065","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/21678707.2016.1226800","article-title":"CFTR modulator therapies in pediatric cystic fibrosis: focus on ivacaftor","volume":"4","author":"Kramer","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"issue":"1","key":"10.1016\/j.jcf.2018.03.010_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/17476348.2016.1122527","article-title":"Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correction","volume":"10","author":"Brewington","year":"2016","journal-title":"Expert Rev Respir Med"},{"issue":"6","key":"10.1016\/j.jcf.2018.03.010_bb0075","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1183\/09031936.00076214","article-title":"Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells","volume":"45","author":"Trinh","year":"2015","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jcf.2018.03.010_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127742","article-title":"Pseudomonas aeruginosa reduces VX-809 stimulated F508del-CFTR chloride secretion by airway epithelial cells","volume":"10","author":"Stanton","year":"2015","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.jcf.2018.03.010_bb0085","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.jcf.2018.03.010_bb0090","first-page":"1","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2018.03.010_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcf.2015.04.002","article-title":"Deleterious impact of hyperglycemia on cystic fibrosis airway ion transport and epithelial repair","volume":"15","author":"Bilodeau","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2018.03.010_bb0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbrc.2012.10.030","article-title":"Mucoid Pseudomonas aeruginosa caused by mucA mutations result in activation of TLR2 in addition to TLR5 in airway epithelial cells","volume":"428","author":"Beaudoin","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.jcf.2018.03.010_bb0105","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1164\/ajrccm\/140.6.1650","article-title":"Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration","volume":"140","author":"Baltimore","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.jcf.2018.03.010_bb0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients","volume":"109","author":"Worlitzsch","year":"2002","journal-title":"J Clin Invest"},{"issue":"NOV","key":"10.1016\/j.jcf.2018.03.010_bb0115","article-title":"Quorum sensing down-regulation counteracts the negative impact of Pseudomonas aeruginosa on CFTR channel expression, function and rescue in human airway epithelial cells","volume":"7","author":"Maill\u00e9","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"10.1016\/j.jcf.2018.03.010_bb0120","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/infdis\/jit059","article-title":"The level of p38\u03b1 mitogen-activated protein kinase activation in airway epithelial cells determines the onset of innate immune responses to planktonic and biofilm Pseudomonas aeruginosa","volume":"207","author":"Beaudoin","year":"2013","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.jcf.2018.03.010_bb0125","doi-asserted-by":"crossref","first-page":"L866","DOI":"10.1152\/ajplung.90224.2008","article-title":"EGF and K+ channel activity control normal and cystic fibrosis bronchial epithelia repair","volume":"295","author":"Trinh","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.jcf.2018.03.010_bb0130","doi-asserted-by":"crossref","first-page":"L945","DOI":"10.1152\/ajplung.00149.2011","article-title":"Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-alpha after injury","volume":"301","author":"Maille","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.jcf.2018.03.010_bb0135","doi-asserted-by":"crossref","first-page":"L1220","DOI":"10.1152\/ajplung.00511.2005","article-title":"Dexamethasone inhibits the action of TNF on ENaC expression and activity","volume":"291","author":"Dagenais","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"Suppl. 2","key":"10.1016\/j.jcf.2018.03.010_bb0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2004.05.010","article-title":"Isolation and air-liquid interface culture of human large airway and bronchiolar epithelial cells","volume":"3","author":"Bals","year":"2004","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2018.03.010_bb0145","doi-asserted-by":"crossref","first-page":"L383","DOI":"10.1152\/ajplung.00403.2005","article-title":"CFTR inhibition mimics the cystic fibrosis inflammatory profile","volume":"292","author":"Perez","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.jcf.2018.03.010_bb0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1085\/jgp.200409059","article-title":"Discovery of glycine hydrazide pore-occluding CFTR inhibitors","volume":"124","author":"Muanprasat","year":"2004","journal-title":"J Gen Physiol"},{"issue":"15","key":"10.1016\/j.jcf.2018.03.010_bb0155","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1111\/bph.12726","article-title":"Revisiting CFTR inhibition: a comparative study of CFTRinh-172 and GlyH-101 inhibitors","volume":"171","author":"Melis","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"246","key":"10.1016\/j.jcf.2018.03.010_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008680","article-title":"Potentiator ivacaftor abrogates pharmacological correction of \u0394F508 CFTR in cystic fibrosis","volume":"6","author":"Cholon","year":"2014","journal-title":"Sci Transl Med"},{"issue":"246","key":"10.1016\/j.jcf.2018.03.010_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3008889","article-title":"Some gating potentiators, including VX-70, diminish DeltaF508-CFTR functional expression","volume":"6","author":"Veit","year":"2014","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.jcf.2018.03.010_bb0170","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bph.13365","article-title":"Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor)","volume":"173","author":"Matthes","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jcf.2018.03.010_bb0175","article-title":"Vx-809\/Vx-770 treatment reduces inflammatory response to Pseudomonas aeruginosa in primary differentiated cystic fibrosis bronchial epithelial cells","author":"Ruffin","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"18","key":"10.1016\/j.jcf.2018.03.010_bb0180","first-page":"1663","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.jcf.2018.03.010_bb0185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.12-1430","article-title":"Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience","volume":"143","author":"Durmowicz","year":"2013","journal-title":"Chest"},{"issue":"20","key":"10.1016\/j.jcf.2018.03.010_bb0190","first-page":"4590","article-title":"Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics HMG advance access","volume":"25","author":"Strug","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.jcf.2018.03.010_bb0195","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/hum.2006.192","article-title":"Pseudomonas aeruginosa infection destroys the barrier function of lung epithelium and enhances polyplex-mediated transfection","volume":"18","author":"Rejman","year":"2007","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.1016\/j.jcf.2018.03.010_bb0200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1165\/rcmb.2003-0056OC","article-title":"Airway epithelial integrity is protected by a long-acting beta2-adrenergic receptor agonist","volume":"30","author":"Coraux","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.jcf.2018.03.010_bb0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-15-21","article-title":"Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells","volume":"15","author":"Nomura","year":"2014","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.jcf.2018.03.010_bb0210","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2017.03.003","article-title":"Real-life initiation of lumacaftor\/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease","volume":"16","author":"Hubert","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2018.03.010_bb0215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coph.2017.09.005","article-title":"Where are we with transformational therapies for patients with cystic fibrosis?","volume":"34","author":"De Boeck","year":"2017","journal-title":"Curr Opin Pharmacol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318300821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318300821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:39:45Z","timestamp":1761601185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199318300821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1569199318300821"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2018.03.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CFTR rescue with VX-809 and VX-770 favors the repair of primary airway epithelial cell cultures from patients with class II mutations in the presence of Pseudomonas aeruginosa exoproducts","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2018.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}